FAMAR’s Business Unit in Anthoussa, Greece, is a specialized manufacturing site dedicated to the production of solid oral dosage forms, serving both prescription (Rx) and over-the-counter (OTC) markets. Its portfolio spans a broad range of therapeutic categories, including painkillers, anti–ulceratives, antifungals, antibiotics (not containing penicillin / cephalosporin), anticoagulants, anti-inflammatories, laxatives, antipsychotics, antacids, beta blockers, anticonvulsants, antihistamines, diuretics, and vasodilator.
The Anthoussa site is committed to delivering outstanding service by providing high-quality products and tailored solutions, while fostering strong, long-term partnerships with both existing and new customers.
FACILITY FACTS
Workforce: 281 employees
Certifications: EU GMP, EAEU GMP, TFDA GMP, Libya GMP, Iraq GMP, ISO9001:2015, ISO14001:2015, ISO45001:2018